DNAJC5 and malaria: In the malaria model, our results are similar to those reported with a replicative Ad5 expressing a P. falciparum CSP B or a T/B cell epitope [66], and to those from a study using an adenovirus expressing a P. yoelii CSP B cell epitope within the HVR1 or the HVR5 and P. yoelii CSP as a transgene [28], as both regimens required between two and three boosting immunizations to induce high antibody titers [28, 66].